Close
Location Selector
Visit the global site -
Mylan.com
Australia
Austria
Belgium
fr
nl
Brazil
Bulgaria
Canada
en
fr
Croatia
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
India
Ireland
Italy
Japan
Malaysia
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
De
En
Taiwan
Thailand
United Kingdom
United States
About Mylan
Better Health
Business Segments
Leadership
Corporate Governance
Products
Biosimilars
Generics
Brand
Over-the-Counter
API
Product Catalog
News
Press Releases
Feature Stories
Mylan in the News
Resources
Fact Sheets
Investors
Leadership
Corporate Governance
Latest News
Events and Presentations
Financials and filings
Stock Information
Shareholder Toolkit
Contact Us
Stock History
Investment Calculator
Stock Performance
Social Responsibility
Serving Patients
Engaging Employees
Environmental Stewardship
Advocating for Access
Forging Partnerships
Supporting Communities
Oversight and Compliance
Careers
Life at Mylan
Mylan Benefits
Diversity and inclusion
Mylan Near You
Mylan Worldwide
News
Press Releases
Feature Stories
Mylan In The News
Resources
Fact Sheets
Press Releases
Year
All Years
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
Category
All Categories
Advocacy
Career
Company
Events
Investor
Products
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Advocacy
Career
Company
Events
Investor
Products
Uncategorized
From
To
Jul 14, 2004
Mylan's Levothyroxine Sodium Tablets Approved as a Generic Equivalent to Levoxyl®
Jul 2, 2004
Mylan Enters Into a Settlement and License Agreement Ending Paclitaxel Litigation
Jul 1, 2004
Mylan's NDA for Nebivolol Accepted for FDA Review
Jun 30, 2004
Mylan Submits a Supplement to Its Citizens Petition Regarding Authorized Generics to the FDA
Jun 29, 2004
Mylan Names Margaret McKenna Chief Business Development Officer
Jun 28, 2004
Mylan Nominates Rod Piatt to its Board of Directors
Jun 25, 2004
Mylan Receives $37.5 Million and Settles All Outstanding Disputes With Schwarz Pharma's KUDCo and Related Parties
Jun 24, 2004
Mylan Receives FDA Approval for Levothyroxine Sodium Tablets
Jun 23, 2004
Mylan Sues FDA for Injunction Against Fentanyl Ruling
Jun 22, 2004
Mylan Laboratories Appoints Michael Marquard President of Mylan Bertek Pharmaceuticals
Show
5
10
25
50
100
per page
«
1
…
105
106
107
108
109
110
111
112
113
»
Tags:
Product
You are leaving Mylan.com
By clicking Continue below you are leaving Mylan.com and going to a third-party site.
Continue
Go back
